1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow CH505w78: new trials by email Literature Review of CH505w78 trials Research Report on CH505w78
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults CH505TF, CH505w53, CH505w78 - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 117 | 2017-08-22 | 2026-05-04 |
HIV Infections (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)
James Kobie (1) · Magda Sobieszczyk (1)